clarithromycin has been researched along with Arrhythmia in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 12 (63.16) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, L; Sun, H | 1 |
| Bies Pivackova, L; Doka, G; Hadova, K; Klimas, J; Kmecova, J; Kralova, E; Krenek, P; Ochodnicka-Mackovicova, K; Stankovicova, T; Vavrinec, P | 1 |
| Jevert-Eichorn, S; Radigan, A | 1 |
| Desai, T; Edhi, AI; Hakim, S | 1 |
| Chen, PH; Chen, ST; Chen, YY; Khan, N; Lin, CK; Papatheodorou, SI; Park, S; You, CH | 1 |
| Anand, S; Chan, EW; Wong, AYS; Wong, ICK; Worsley, AJ | 1 |
| Gorelik, E; Masarwa, R; Matok, I; Muszkat, M; Perlman, A; Rotshild, V | 1 |
| Karmakar, S; Padman, A; Sen, T; Swamy Mane, N | 1 |
| Nilsson, MF; Webster, WS | 1 |
| Chan, KA; Chang, CH; Chou, HW; Lai, CL; Lai, MS; Wang, JL | 1 |
| Dixon, SN; Garg, AX; Hackam, DG; Jandoc, R; McArthur, E; Nash, DM; Trac, MH | 1 |
| Li, C; Li, X; Liu, G; Wang, M; Wang, Z; Zhou, L | 1 |
| Bannister, CA; Berni, E; Butler, CC; Currie, CJ; de Voogd, H; Halcox, JP; Jenkins-Jones, S; Jones, B; Ouwens, M | 1 |
| Biertz, J; Breithardt, G; Bruns, HJ; Eckardt, L; Fabritz, L; Fleischer, D; Haverkamp, W; Kirchhof, P; Milberg, P; Ramtin, S; Reinsch, N | 1 |
| Bagnardi, V; Botteri, E; Carobbio, A; Corrao, G; Falcone, C; Leoni, O; Zambon, A | 1 |
| Burton, DY; Campbell, B; Connolly, JM; Defelice, S; Hoffman, A; Levy, RJ; Perlstein, I; Ryan, K; Simmers, E | 1 |
| Hashimoto, T; Hayashi, Y; Ikeda, U; Mitsuhashi, T; Shimada, K; Watanabe, T | 1 |
| Hanada, E; Iga, T; Kotaki, H; Ohtani, H; Sato, H; Sawada, Y; Taninaka, C | 1 |
3 review(s) available for clarithromycin and Arrhythmia
| Article | Year |
|---|---|
Clarithromycin use and the risk of mortality and cardiovascular events: A systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Cardiovascular Diseases; Cause of Death; Clarithromycin; Humans; Myocardial Infarction; Risk Factors | 2019 |
Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis.
Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Cardiovascular Diseases; Clarithromycin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Macrolides; Myocardial Infarction; Observational Studies as Topic; Randomized Controlled Trials as Topic; Risk Factors; Stroke | 2017 |
Systematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of Macrolides.
Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Clarithromycin; Erythromycin; Macrolides; Myocardial Infarction; Network Meta-Analysis; Risk Factors | 2018 |
16 other study(ies) available for clarithromycin and Arrhythmia
| Article | Year |
|---|---|
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Rapid changes of mRNA expressions of cardiac ion channels affected by Torsadogenic drugs influence susceptibility of rat hearts to arrhythmias induced by Beta-Adrenergic stimulation.
Topics: Adrenergic Agents; Animals; Arrhythmias, Cardiac; Calcium Channels; Clarithromycin; DNA-Binding Proteins; Furosemide; Long QT Syndrome; Pharmaceutical Preparations; Rats; RNA, Messenger | 2023 |
Rare case of pacemaker infection with
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Arrhythmias, Cardiac; Cefoxitin; Clarithromycin; Clofazimine; Drug Resistance, Bacterial; Epidural Abscess; Heroin Dependence; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Osteomyelitis; Pacemaker, Artificial; Prosthesis-Related Infections | 2019 |
Eradicating H. pylori.
Topics: Adenocarcinoma; Anti-Bacterial Agents; Arrhythmias, Cardiac; Clarithromycin; Drug Therapy, Combination; Esophageal Neoplasms; Helicobacter Infections; Helicobacter pylori; Humans; Mortality; Myocardial Infarction; Patient Selection; Practice Guidelines as Topic; Quinolones; Risk; Risk Assessment; Stomach Neoplasms; United States | 2019 |
Clarithromycin in patients with coronary artery disease.
Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Bacterial Infections; Clarithromycin; Coronary Artery Disease; Humans; Risk Factors | 2018 |
Hypokalemia: a potent risk for QTc prolongation in clarithromycin treated rats.
Topics: Animals; Anti-Bacterial Agents; Arrhythmias, Cardiac; Clarithromycin; Dietary Supplements; Disease Models, Animal; Disease Susceptibility; Dose-Response Relationship, Drug; Electrocardiography; Electrolytes; Furosemide; Heart; Hypokalemia; Male; Potassium, Dietary; Rats; Rats, Wistar; Risk Factors; Severity of Illness Index; Suspensions | 2013 |
Effects of macrolide antibiotics on rat embryonic heart function in vitro.
Topics: Abnormalities, Drug-Induced; Animals; Anti-Bacterial Agents; Arrhythmias, Cardiac; Bradycardia; Clarithromycin; Dose-Response Relationship, Drug; Embryo Culture Techniques; Erythromycin; Female; Heart; Macrolides; Male; Rats; Rats, Sprague-Dawley; Teratogens | 2014 |
Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; beta-Lactamase Inhibitors; Cardiovascular Diseases; Ciprofloxacin; Clarithromycin; Comorbidity; Female; Fluoroquinolones; Humans; Levofloxacin; Logistic Models; Male; Moxifloxacin; Risk; Taiwan | 2015 |
Macrolide antibiotics and the risk of ventricular arrhythmia in older adults.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; Clarithromycin; Cohort Studies; Erythromycin; Female; Humans; Logistic Models; Macrolides; Male; Ontario; Propensity Score; Retrospective Studies; Risk Assessment; Risk Factors | 2016 |
Macrolides use and the risk of sudden cardiac death.
Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; Clarithromycin; Coronary Artery Disease; Coronary Disease; Death, Sudden, Cardiac; Erythromycin; Humans; Macrolides; Plaque, Atherosclerotic; Risk Factors; Torsades de Pointes | 2016 |
Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Arrhythmias, Cardiac; Cardiovascular Diseases; Cause of Death; Clarithromycin; Doxycycline; Erythromycin; Female; Humans; Male; Middle Aged; Respiratory Tract Infections; Risk Factors; United Kingdom | 2017 |
Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
Topics: Animals; Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; Blood Pressure; Clarithromycin; Electrocardiography; Erythromycin; Heart; Heart Rate; In Vitro Techniques; Long QT Syndrome; Male; Rabbits; Time Factors; Torsades de Pointes | 2002 |
Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials.
Topics: Adverse Drug Reaction Reporting Systems; Anti-Bacterial Agents; Arrhythmias, Cardiac; Case-Control Studies; Ciprofloxacin; Clarithromycin; Cohort Studies; Community Health Planning; Databases, Factual; Drug Monitoring; Erythromycin; Humans; Italy; Levofloxacin; Miocamycin; Norfloxacin; Ofloxacin; Pharmacoepidemiology; Risk Factors | 2005 |
Posttranslational control of a cardiac ion channel transgene in vivo: clarithromycin-hMiRP1-Q9E interactions.
Topics: Action Potentials; Amino Acid Substitution; Animals; Arrhythmias, Cardiac; Clarithromycin; Echocardiography; Electrophysiology; Gene Expression; Genetic Therapy; Green Fluorescent Proteins; Heart Atria; Mutation; Potassium Channels, Voltage-Gated; Protein Processing, Post-Translational; Swine; Transfection; Transgenes | 2005 |
Torsades de pointes ventricular tachycardia induced by clarithromycin and disopyramide in the presence of hypokalemia.
Topics: Aged; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Arrhythmias, Cardiac; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Disopyramide; Electrocardiography; Female; Humans; Hypokalemia; Mixed Function Oxygenases; Myocardial Infarction; Respiratory Tract Infections; Torsades de Pointes | 1999 |
Comparative pharmacodynamic analysis of Q-T interval prolongation induced by the macrolides clarithromycin, roxithromycin, and azithromycin in rats.
Topics: Algorithms; Animals; Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; Body Temperature; Clarithromycin; Electrocardiography; Heart Rate; Infusions, Intravenous; Male; Models, Biological; Rats; Rats, Sprague-Dawley; Roxithromycin | 2000 |